HYBRIMS

HYBRID IMAGING SYSTEMS, S.L. (HYBRIMS) is a company dedicated to the design, development, manufacturing and marketing of medical devices based on imaging technologies for the precise diagnosis of cancer, facilitating personalized medicine to improve the clinical prognosis of the patient.

HYBRIMS is a Knowledge-Based Company (EBC or spin-off) of the Spanish National Research Council (CSIC) and the University of Valencia (UV) created from the development of a patented medical technology that combines gamma and ultrasound images with the capacity to guide cancer biopsies in real time. This novel device adds the metabolic information provided by gamma images, which display the most active or aggressive areas of the tumor, to the morphological information obtained with ultrasound, allowing the specialist to obtain more precise information about the tumor. The combination of both information ensures the biopsy of the most representative samples possible of the tumor and lymph nodes,

- allowing for personalized and precise oncological treatment

- improving the patient's diagnosis and prognosis

- reducing the overall costs of cancer treatment

- decreasing the patient's pain, stress and anxiety